Registration

2017 1st Quarter (Jan 1 - Mar 31) Foreign Entity
Income
—
Expenses
—
Official Senate LDA Document

Lobbying Activities

Healthcare issues related to clinical laboratories; FDA oversight of laboratory developed tests; Medicare reimbursement levels for laboratory services; General environmental issues affecting steel production; Any and all energy issues, as they pertain to the steel industry; General trade legislation, as it relates to unfair trade practices and trade law enforcement; Issues related to corporate tax reform; Issues related to transportation infrastructure
Healthcare issues related to clinical laboratories; FDA oversight of laboratory developed tests; Medicare reimbursement levels for laboratory services; General environmental issues affecting steel production; Any and all energy issues, as they pertain to the steel industry; General trade legislation, as it relates to unfair trade practices and trade law enforcement; Issues related to corporate tax reform; Issues related to transportation infrastructure
Healthcare issues related to clinical laboratories; FDA oversight of laboratory developed tests; Medicare reimbursement levels for laboratory services; General environmental issues affecting steel production; Any and all energy issues, as they pertain to the steel industry; General trade legislation, as it relates to unfair trade practices and trade law enforcement; Issues related to corporate tax reform; Issues related to transportation infrastructure
Healthcare issues related to clinical laboratories; FDA oversight of laboratory developed tests; Medicare reimbursement levels for laboratory services; General environmental issues affecting steel production; Any and all energy issues, as they pertain to the steel industry; General trade legislation, as it relates to unfair trade practices and trade law enforcement; Issues related to corporate tax reform; Issues related to transportation infrastructure
Healthcare issues related to clinical laboratories; FDA oversight of laboratory developed tests; Medicare reimbursement levels for laboratory services; General environmental issues affecting steel production; Any and all energy issues, as they pertain to the steel industry; General trade legislation, as it relates to unfair trade practices and trade law enforcement; Issues related to corporate tax reform; Issues related to transportation infrastructure
Healthcare issues related to clinical laboratories; FDA oversight of laboratory developed tests; Medicare reimbursement levels for laboratory services; General environmental issues affecting steel production; Any and all energy issues, as they pertain to the steel industry; General trade legislation, as it relates to unfair trade practices and trade law enforcement; Issues related to corporate tax reform; Issues related to transportation infrastructure
Healthcare issues related to clinical laboratories; FDA oversight of laboratory developed tests; Medicare reimbursement levels for laboratory services; General environmental issues affecting steel production; Any and all energy issues, as they pertain to the steel industry; General trade legislation, as it relates to unfair trade practices and trade law enforcement; Issues related to corporate tax reform; Issues related to transportation infrastructure

Foreign Entities

ARCELORMITTAL
Country: Luxembourg Ownership: 100.0%

Affiliated Organizations

ALLIANCE FOR AMERICAN MANUFACTURING
Washington, DC, US
ARCELORMITTAL USA
Washington, DC, US
LABORATORY CORPORATION OF AMERICA HOLDINGS
Burlington, NC, US
SPECIALTY STEEL INDUSTRY OF NORTH AMERICA
Washington, DC, US